Intra-Articular Hip Injection
Intra-Articular Hip Injection
Intra-Articular Hip Injection
An image-guided intra-articular hip injection places medication directly into the hip joint. Corticosteroid injection may be considered for selected patients with symptomatic hip osteoarthritis to improve pain and function in the short term.
The injection does not reverse osteoarthritis, restore lost cartilage, or guarantee avoidance of hip replacement. Hip pain can also originate outside the joint, so confirming the likely pain generator is important before injection.
Procedure and Risks
Fluoroscopy or ultrasound is used to guide needle placement. Potential risks include temporary pain flare, bleeding, infection, medication reaction, transient blood-glucose elevation, skin/tissue changes, and rare joint complications. Published orthopedic guidelines also note concern about rapidly progressive osteoarthritis after intra-articular corticosteroid exposure, although the absolute risk and causal relationship remain subjects of study.
Clinical Evidence, Limitations & Patient Selection
AAOS states that intra-articular corticosteroid can be considered to improve pain and function in symptomatic hip osteoarthritis in the short term.
Important limitation: Injection does not reverse osteoarthritis and carries injection/steroid risks, including a rare concern for rapidly progressive OA.
Every procedure has potential risks, and individual benefit cannot be guaranteed. Recommendations at Solutions in Pain are based on the diagnosis, examination, relevant imaging, prior treatment, medical history, medications, patient goals, current evidence, and applicable payer requirements.
Selected Evidence & Guidelines
Patient-education content updated September 2026. This information does not replace an individualized medical evaluation or informed-consent discussion.
